🔍 Observations
Topline
- Revenue surged 46% YoY (₹10,981M → ₹16,032M), with Q4FY26 alone at ₹4,799M — 40% above Q4FY25 (₹3,428M), signalling sustained demand acceleration, not a one-quarter aberration.
- Sequential Q3→Q4 growth of 15% (₹4,175M → ₹4,799M) confirms momentum is building within the year, not plateauing.
- Revenue scale has nearly 1.5x’d in a single year — exceptional for an EMS player and indicative of wallet-share gains or new programme ramp-ups with existing clients.
Bottomline
- Net profit more than doubled YoY: ₹634M → ₹1,129M (+78%), with EPS rising from ₹9.62 to ₹16.95 (basic) — a significant re-rating trigger.
- Q4FY26 PAT of ₹412M is 69% above Q4FY25 (₹243M), and 26% above Q3FY26 (₹326M) — sequential as well as annual acceleration intact.
- Effective tax rate held steady at ~26.5% (₹407M on ₹1,536M PBT), so profit growth is operationally driven, not tax-benefit inflated.
Margins
- EBITDA (PBT + Finance costs + D&A): FY26 = ₹1,536M + ₹150M + ₹336M = ₹2,022M on revenue of ₹16,032M → EBITDA margin ~12.6% vs FY25: (₹867M + ₹167M + ₹286M) / ₹10,981M = ₹1,320M / ₹10,981M = ~12.0%. Modest but meaningful 60bps expansion.
- Net profit margin improved from 5.8% (₹634M / ₹10,981M) to 7.0% (₹1,129M / ₹16,032M) — 120bps expansion at PAT level, better than EBITDA expansion, reflecting lower finance costs as a share of revenue.
- Employee costs rose from 18.1% of revenue (FY25) to 17.5% (FY26) — operational leverage visible in the largest cost head after raw materials.
Growth Trajectory
- Revenue CAGR implied over 1 year: 46%. Raw material consumption grew from ₹7,188M to ₹11,061M (+54%), slightly outpacing revenue — worth monitoring for input cost pass-through efficiency.
- PAT growth (78%) decisively outpacing revenue growth (46%) = positive operating leverage at work.
- Q4FY26 run-rate of ~₹4,800M implies annualised revenue of ~₹19,200M — suggesting FY27 organic growth could sustain 15–20%+ even without fresh programme additions.
🧮 Profit & Loss Statement
🧮 Balance Sheet
🧮 Cash Flows Statement
🟢 Green Flags
- 78% PAT growth YoY signals strong operating leverage — fixed cost base not scaling proportionately with revenue.
- EBITDA margin expansion to ~12.6% despite 46% revenue scale-up demonstrates cost discipline across the P&L.
- Finance costs declining as % of revenue (1.52% FY25 → 0.94% FY26) as the business generates more profit to service debt organically.
- Q4 exit velocity (₹4,799M revenue, ₹412M PAT) sets a high base and provides strong FY27 earnings visibility.
- Equity base stable — share capital at ₹133.5M, minimal dilution, so EPS growth is genuinely value-accretive to existing shareholders.
- Other equity grew from ₹5,983M to ₹7,084M, entirely driven by retained earnings — no equity raise, no dilution.
- Operating cash flow doubled (₹251M → ₹572M), confirming that profit growth is partially converting to cash, not purely accrual.
🔴 Red Flags
- Inventory surge: ₹3,379M → ₹4,633M (+37%) — the single largest working capital drag; if order momentum slows, this becomes an inventory risk.
- OCF/PAT conversion weak: PAT of ₹1,129M but OCF only ₹572M — 51% conversion. Working capital consumed ~₹1,047M net of adjustments, limiting free cash generation.
- Free cash flow negative: OCF ₹572M minus capex ₹536M = FCF ~₹36M — effectively zero. Growth is being funded by working capital borrowing, not internal accruals.
- Short-term borrowings spiked: ₹1,233M → ₹1,723M (+40%), tracking inventory and receivable build — introduces refinancing and interest rate risk.
- Receivables elevated: ₹3,160M → ₹3,813M (+20%); receivable days = (₹3,813M / ₹16,032M) × 365 ≈ 87 days — stretched for an EMS business.
- Expected credit loss provision added ₹41.6M vs ₹11.6M in FY25 — early signal of receivable quality deterioration worth watching.
- Negative comprehensive income gap: Total comprehensive income (₹1,066M) trails PAT (₹1,129M) — ₹63M absorbed by other comprehensive income items, likely forex/actuarial losses.
📊 Balance Sheet Analysis
- Leverage is manageable but rising: Total borrowings (current + non-current) = ₹1,834M vs equity of ₹7,217M → D/E of 0.25x. Low absolute leverage, but the 40% YoY increase in short-term debt demands monitoring.
- Working capital intensity is high: Net working capital = Current Assets (₹10,174M) – Current Liabilities (₹4,959M) = ₹5,215M vs ₹4,481M in FY25 — a ₹734M incremental funding requirement absorbed in one year.
- Asset quality solid: Tangible assets well-supported; CWIP at ₹239M signals active capacity investment. Goodwill/intangible risk is minimal (₹64M).
- Liquidity adequate near-term: Cash + current investments = ₹712M + ₹717M = ₹1,429M against short-term borrowings of ₹1,723M — covered, but not comfortable.
💰 Cash Flow Analysis
- OCF of ₹572M on PBT of ₹1,536M — working capital consumed ₹1,048M net, with inventory alone accounting for ₹1,165M outflow.
- Investing outflow of ₹636M driven by ₹536M capex + ₹364M mutual fund deployment, partially offset by FD redemptions of ₹326M — growth investment is active.
- Financing inflow of ₹79M was net positive only because short-term borrowings rose ₹409M; net of that, the business returned preference share capital (₹77M) and paid interest (₹114M).
- Net cash change: +₹15M — the business is in a high-growth, cash-consuming phase; profitability is real but free cash flow generation remains a work-in-progress.
💡 Investment Outlook
Avalon Technologies has delivered a genuine earnings inflection in FY26 — 46% revenue growth, 78% PAT growth, and expanding margins confirm this is an operating leverage story, not a one-off.
The near-zero FCF and rising short-term debt are not alarm signals yet, but they cap near-term re-rating unless working capital efficiency improves and inventory converts to cash.
The Q4FY26 run-rate implies meaningful FY27 earnings visibility, making the margin trajectory and receivables cycle the two most critical variables to track.
Investors comfortable with EMS sector working capital dynamics and confident in order book durability will find the growth profile compelling; those focused on cash returns should wait for FCF conversion to improve.
Disclaimer: This post features ChartAlert-AI-generated financial content which may contain inaccuracies or errors. This commentary is strictly for informational purposes and does not constitute a recommendation to buy or sell any security. Investors are responsible for performing their own due diligence; always consult with a licensed financial advisor before making investment decisions.
Beyond the Price Action: Fundamental Analysis is Coming to ChartAlert
ChartAlert is evolving into integrated research with a future update that will embed fundamental data into your workflow. Alongside technical analysis, the new release will allow access to financial data, quarterly results review, earnings call transcripts, and valuation tools, connecting price action with corporate performance for smarter, data‑driven decisions.